Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11359026 High concentration antibody-containing liquid formulation
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
April 27, 2021
0
Date of Patent
June 14, 2022
0
Patent Application Number
17242199
0
Patent Citations
US Patent 10961314 Liquid pharmaceutical composition comprising an anti-IL-6 receptor antibody
0
US Patent 11021728 Method for the production of a glycosylated immunoglobulin
0
US Patent 11008394 High concentration antibody-containing liquid formulation
0
US Patent 10022319 Stabilized antibody-containing liquid formulations
US Patent 10166293 Reduced-viscosity concentrated protein formulations
US Patent 10168326 Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
US Patent 10316096 Stabilized antibody-containing formulations
US Patent 10231981 Subcutaneously administered anti-IL-6 receptor antibody for treatment of juvenile idiopathic arthritis
US Patent 10349940 Surgical stapler buttress applicator with state indicator
US Patent 10590164 Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
•••
Patent Inventor Names
Daisuke Kameoka
0
Oliver Boris Stauch
0
Terutoshi Maeda
0
Toshiyuki Morichika
0
Yoshimi Imaeda
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11359026
0
Patent Primary Examiner
Gary B. Nickol
0
Find more entities like US Patent 11359026 High concentration antibody-containing liquid formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE